Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial

Journal of Consulting and Clinical Psychology

Volumn 80, Issue 3, 2012, Pages 404-415

  Safren, Steven A ^a   O'Cleirigh, Conall M ^a   Bullis, Jacqueline R ^b   Otto, Michael W ^b   Stein, Michael D ^c   Pollack, Mark H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

adherence; antiretroviral therapy (ART); depression; HIV AIDS; substance abuse

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION DRUG USE; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; TREATMENT WITHDRAWAL; ADDICTION; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COGNITIVE THERAPY; DEPRESSIVE DISORDER; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84865511362     PISSN: 0022006X     EISSN: 19392117     Source Type: Journal    
DOI: 10.1037/a0028208     Document Type: Article

References (56)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Amico, K. R., Harman, J. J., & Johnson, B. T. (2006). Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004. Journal of Acquired Immune Deficiency Syndromes, 41, 285-297.
3. Antoni, M. H., Carrico, A. W. Durán, R. E., Spitzer, S., Penedo, F., Ironson, G., . . . Schneiderman, N. (2006). Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosomatic Medicine, 68, 143-151. doi:10.1097/01.psy.0000195749.60049.63
4. Attia, S., Egger, M., Muller, M., Zwahlen, M., & Low, N. (2009). Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS, 23, 1397-1404. doi: 10.1097/QAD.0b013e32832b7dca
5. Avants, S. K., Margolin, A., Warburton, L. A., Hawkins, K. A., & Shi, J. (2001). Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. American Journal of Addictions, 10, 69-78.
6. Bangsberg, D. R. (2006). Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases, 43, 939-941. doi:10.1086/507526
7. Beck, A. T., & Beck, R. W. (1972). Screening depressed patients in family practice. A rapid technic. Postgraduate Medicine, 52, 81-85.
8. Berger-Greenstein, J. A., Cuevas, C. A., Brady, S. M., Trezza, G., Richardson, M. A., & Keane, T. M. (2007). Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care and STDs, 21, 942-955. doi:10.1089/apc.2006.0153
9. Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., . . . Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721-728. doi: 10.1001/archpsyc.58.8.721
10. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133. doi:10.1037/0278-6133.19.2.124
11. Centers for Disease Control and Prevention. (2008). HIV prevalence estimates: United States, 2006. Morbidity and Mortality Weekly Report, 57, 1073-1076.
12. Centers for Disease Control and Prevention. (2008). Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2008. HIV Statistics and Surveillance, 20. Retrieved from http://www.cdc.gov/hiv/ surveillance/resources/reports/2008report/
13. Ciesla, J. A., & Roberts, J. E. (2001). Meta-analysis of the relationship between HIV infection and risk for depressive disorders. American Journal of Psychiatry, 158, 725-730. doi:10.1176/appi.ajp.158.5.725
14. Deschamps, A. E., Van Wijngaerden, E., Denhaerynck, K., De Geest, S., & Vandamme, A. M. (2006). Use of electronic monitoring induces a 40-day intervention effect in HIV patients. Journal of Acquired Immune Deficiency Syndromes, 43, 247-248. doi:10.1097/01.qai.0000 246034.86135.89
15. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101-2107. doi:10.1001/archinte.160.14.2101
16. Feingold, A. (2009). Effect sizes for growth-modeling analysis for controlled trials in the same metric as for classical analysis. Psychological Methods, 14, 43-53. doi:10.1037/a0014699
17. Garća de Olalla, P., Knobel, H., Carmona, A., Guelar, A., López-Colomés, J. L., & Caylà, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 30, 105-110.
18. Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment nonadherence: A review and metaanalysis. Journal of Acquired Immune Deficiency Syndromes, 58, 181-187.
19. Hull, M. W., & Montaner, J. (2011). Antiretroviral therapy: A key component of a comprehensive HIV prevention strategy. Current HIV/AIDS Reports, 8, 85-93. doi:10.1007/s11904-011-0076-6
20. Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., . . . Moore, J. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. Journal of the American Medical Association, 285, 1466-1474. doi: 10.1001/jama.285.11.1466
21. Ironson, G., O'Cleirigh, C., Fletcher, M. A., Laurenceau, J. P., Balbin, E., Klimas, N., . . . Solomon, G. (2005). Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosomatic Medicine, 67, 1013-1021. doi:10.1097/01.psy.0000188569.58998.c8
22. Keiser, O., Spycher, B., Rauch, A., Calmy, A., Cavassini, M., Glass, T. R., . . . Egger, M. (2012). Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: Latent class analysis. AIDS and Behavior, 16, 245-255.
23. Leserman, J. (2003). HIV disease progression: Depression, stress, and possible mechanisms. Biological Psychiatry, 54, 295-306. doi:10.1016/S0006- 3223(03)00323-8
24. Leserman, J. (2008). Role of depression, stress, and trauma in HIV disease progression. Psychosomatic Medicine, 70, 539-545. doi:10.1097/PSY. 0b013e3181777a5f
25. Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., . . . Wenger, N. S. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-977.
26. Liu, H., Miller, L. G., Hays, R. D., Golin, C. E., Wu, T., Wenger, N. S., & Kaplan, A. H. (2006). Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. Journal of Acquired Immune Deficiency Syndromes, 41, 315-322. doi:10.1097/01.qai.0000 197071.77482.6e
27. Llabre, M. M., Weaver, K. E., Duran, R. E., Antoni, M. H., McPherson-Baker, S., & Schneiderman, N. (2006). A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Care and STDs, 20, 701-711. doi:10.1089/apc.2006.20.701
28. Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 27, 251-259.
29. Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 16, 767-774. doi:10.1097/00002030- 200203290-00012
30. Lucas, G. M., Mullen, B. A., McCaul, M. E., Weidle, P. J., Hader, S., & Moore, R. D. (2007). Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS Patient Care and STDs, 21, 564-574. doi:10.1089/apc.2006.0192
31. Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389. doi:10.1192/bjp.134.4.382
32. Müller, M. J., Himmerich, H., Kienzle, B., & Szegedi, A. (2003). Differentiating moderate and severe depression using the Montgomery-Asberg Depression Rating Scale (MADRS). Journal of Affective Disorders, 77, 255-260. doi:10.1016/S0165-0327(02)00120-9
33. National Institute of Mental Health. (1985). CGI (Clinical Global Impression) Scale-NIMH. Psychopharmacology Bulletin, 21, 839-844.
34. Nezu, A. M., Nezu, C. M., Felgoise, S. H., McClure, K. S., & Houts, P. S. (2003). Project Genesis: Assessing the efficacy of problem-solving therapy for distressed adult cancer patients. Journal of Consulting and Clinical Psychology, 71, 1036-1048. doi:10.1037/0022-006X.71.6.1036
35. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., . . . Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
36. Petrie, K. J., Fontanilla, I., Thomas, M. G., Booth, R. J., & Pennebaker, J. W. (2004). Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: A randomized trial. Psychosomatic Medicine, 66, 272-275. doi:10.1097/01.psy.0000116782.49850. d3
37. Raudenbush, S. W., Bryk, A. S., Cheong, Y. F., & Congdon, R. T. (2004). HLM 6: Hierarchical linear and nonlinear modeling (Version 6.06). Chicago, IL: Scientific Software International.
38. Raudenbush, S. W., & Liu, X. (2001). Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change. Psychological Methods, 6, 387-401. doi: 10.1037/1082-989X.6.4.387
39. Riera, M., La Fuente, L., Castanyer, B., Puigventos, F., Villalonga, C., Ribas, M. A., . . . Salas, A. (2002). Adherence to antiretroviral therapy measured by pill count and drug serum concentrations: Variables associated with bad adherence. Medicina Clinica, 119, 286-292.
40. Robertson, I. (1983). A comparison of depression rating scales. British Journal of Psychiatry, 142, 423b-425b. doi:10.1192/bjp.142.4.423b
41. Ruiz Perez, I., Rodriguez Bano, J., Lopez Ruz, M. A., del Arco Jimenez, A., Causse Prados, M., Pasquau Liano, J., . . . Marcos, M. (2005). Health-related quality of life of patients with HIV: Impact of sociodemographic, clinical and psychosocial factors. Quality of Life Research, 14, 1301-1310. doi:10.1007/s11136-004-4715-X
42. Safren, S. A., Gonzalez, J. S., & Soroudi, N. (2007a). Coping with chronic illness: Cognitive behavioral therapy for adherence and depression in individuals with chronic illness, Client workbook. New York, NY: Oxford University Press.
43. Safren, S. A., Gonzalez, J. S., & Soroudi, N. (2007b). Coping with chronic illness: Cognitive behavioral therapy for adherence and depression in individuals with chronic illness, Therapist guide. New York, NY: Oxford University Press.
44. Safren, S. A., Hendriksen, E. S., DeSousa, N., Boswell, S. L., & Mayer, K. H. (2003). Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care, 15, 787-793. doi:10.1080/ 09540120310001618630
45. Safren, S. A., Hendriksen, E. S., Mayer, K. H., Mimiaga, M. J., Pickard, R., & Otto, M. W. (2004). Cognitive behavioral therapy for HIV medication adherence and depression. Cognitive and Behavioral Practice, 11, 415-424. doi:10.1016/S1077-7229(04)80058-0
46. Safren, S. A., O'Cleirigh, C., Tan, J. Y., Raminani, S. R., Reilly, L. C., Otto, M. W., & Mayer, K. H. (2009). A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology, 28, 1-10. doi:10.1037/a0012715
47. Safren, S. A., Otto, M. W., & Worth, J. L. (1999). Life-steps: Applying cognitive behavioral therapy to HIV medication adherence. Cognitive and Behavioral Practice, 6, 332-341. doi:10.1016/S1077-7229 (99)80052-2
48. Safren, S. A., Otto, M. W., Worth, J. L., Salomon, E., Johnson, W., Mayer, K., & Boswell, S. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behaviour Research and Therapy, 39, 1151-1162. doi:10.1016/S0005-7967(00)00091-7
49. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., . . . Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M. I. N. I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl. 20), 22-33.
50. Simoni, J. M., Amico, K. R., Pearson, C. R., & Malow, R. (2008). Strategies for promoting adherence to antiretroviral therapy: A review of the literature. Current Infectious Disease Reports, 10, 515-521. doi: 10.1007/s11908-008-0083-y
51. Simoni, J. M., Frick, P. A., Pantalone, D. W., & Turner, B. J. (2003). Antiretroviral adherence interventions: A review of current literature and ongoing studies. Topics in HIV Medicine, 11, 185-198.
52. Simoni, J. M., Pearson, C. R., Pantalone, D. W., Marks, G., & Crepaz, N. (2006). Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl. 1), S23-S35. doi:10.1097/01.qai.0000248342.05438.52
53. Springer, S. A., Chen, S., & Altice, F. (2009). Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Care, 21, 976-983. doi:10.1080/09540120802657555
54. Thompson, M. A., Aberg, J. A., Cahn, P., Montaner, J. S., Rizzardini, G., Telenti, A., . . . Schooley, R. T. (2010). Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. Journal of the American Medical Association, 304, 321-333. doi:10.1001/jama. 2010.1004
55. Wagner, G. J., & Ghosh-Dastidar, B. (2002). Electronic monitoring: Adherence assessment or intervention HIV Clinical Trials, 3, 45-51. doi:10.1310/XGXU-FUDK-A9QT-MPTF
56. Weber, R., Huber, M., Rickenbach, M., Furrer, H., Elzi, L., Hirschel, B., & Ledergerber, B. (2009). Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: The Swiss HIV Cohort Study. HIV Medicine, 10, 407-416. doi:10.1111/j.1468-1293.2009.00701.x